Navigation Links
Profusa, Inc. Announces $13.2 Million Series B to Support Development of Internal Biosensors for Continuous Monitoring of Body Chemistry
Date:12/16/2015

SOUTH SAN FRANCISCO, Calif., Dec. 16, 2015 /PRNewswire/ -- Profusa, Inc., based here, today announced it secured $13.2 million in Series B financing to support the development and com­mercialization of its internal biosensor technology for long-term, continuous monitoring of body chemistry for improving personal health and managing disease. 3E Bioventures, a Beijing-based venture capital firm, led the round with Asset Management Ventures, Qihoo 360, and other Series A investors participating in the funding. All told, including non-dilutive grants, the new financing brings to the privately held company more than $30 million in funding since its founding in 2009. Other financial details were not disclosed.

Profusa also said it appointed to its board of directors Joan Braddi, Vice President of Global Product Partnerships at Google, Inc., a subsidiary of Alphabet Inc. Karen Liu, Ph.D., Managing Partner of 3E Bioventures, also joined Profusa's board in conjunction with her firm's investment in the Series B round.

"This round, coupled with prominent board appointments from the biotechnology and IT sectors, provide Profusa with the additional funding and market experience to help ensure our success," said Ben Hwang, Ph.D., Profusa's chairman and CEO.

As Google's 15th employee for as many years, Braddi is responsible for building and man­aging content and distribution partnerships that get Google's products into the hands of users around the world. Dr. Liu heads 3E Bioventures' investing in the U.S. and China, and is active in creating cross-border opportunities in healthcare.

Profusa, Inc. is leading the development of a new generation of biologically integrated sensors that empowers an individual with the ability to continuously monitor their unique body chemistry in unprecedented ways to transform the management of personal health and disease. Overcoming the body's response to foreign material, the company's technology enables the development of minute bioengineered sensors that become one with the body to detect and transmit clinical-grade data for personal and medical use. The company's first product, the Lumee Oxygen Sensing System™, is slated to be available in Europe in early 2016 for the measurement of tissue-oxygen perfusion in the clinical management of chronic wounds.

Logo - http://photos.prnewswire.com/prnh/20151215/296354LOGO

 


'/>"/>
SOURCE Profusa, Inc.
Copyright©2015 PR Newswire.
All rights reserved


Related biology technology :

1. DistinctBright, Probiotic Cleaner, Announces their Probiotic Cleaner is Safe for Pets
2. Annual Conference about Technology Solutions for People with Disabilities Announces Program
3. Probiotic Action Announces Probiotics Lead the Digestive Health Market
4. Verenium Announces Preliminary Financial Results For Fiscal 2012
5. Senomyx Announces Fourth Quarter And Full Year 2012 Financial Results And Initiation Of New Direct Sales Strategy
6. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
7. EAG Announces New General Manager of Release-To-Production (RTP) Division
8. DuPont Tate & Lyle Bio Products Announces Novel Application for Zemea® Propanediol
9. Probiotic Action Announces China’s $5 Billion Dollar Investment in Probiotics
10. EAS Consulting Group, Experts in Quality Regulatory Services Related to FDA Issues, Announces Upcoming Dietary Supplement Seminars in Salt Lake City
11. 3D Biomatrix Announces Stipend to Present at Spring 2013 Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , Belgium , March 28, 2017 ... VolitionRx Limited (NYSE MKT: VNRX), today announced the engagement of ... DVD Associates, LLC, as a strategic consultant. Dr. Vollmer ... identifying and securing non-dilutive funding in the State ... United States . Dr. Vollmer Dahlke has ...
(Date:3/28/2017)... -- Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or ... to treat cancers and other life-threatening conditions of the ... McGorry, CEO of Biostage, will present on the ... MassBio 2017 Annual Meeting on Thursday, March ... The 3D Printing and BioEngineering panel will ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... its brand-new, fully-certified hygienic SWB805 MultiMountTM weigh modules. These weigh modules are ... certified by National Sanitation Foundation (NSF). , As fully integrated weighing solutions, ...
(Date:3/27/2017)... , March 27, 2017 Roka Bioscience, Inc. ... testing solutions for the detection of foodborne pathogens,  today announced ... Sidoti & Company Spring 2017 Convention on March 29 at ... York Marriott Marquis. About Roka Bioscience ... Roka ...
Breaking Biology Technology:
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
(Date:3/23/2017)... India , March 23, 2017 The report "Gesture ... Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, ... at a CAGR of 29.63% between 2017 and 2022. ... ... ...
(Date:3/22/2017)... , March 21, 2017 Optimove ... used by retailers such as 1-800-Flowers and AdoreMe, ... — Product Recommendations and Replenishment. Using Optimove,s machine learning ... personalized product and replenishment recommendations to their customers ... on predictions of customer intent drawn from a ...
Breaking Biology News(10 mins):